Crossmark

Comparative Genomic, Transcriptomic, and Proteomic Analysis of the Limosilactobacillus fermentum U-21 Strain Promising for the Creation of a Pharmabiotic

Crossref DOI link: https://doi.org/10.1134/S1022795422090125

Published Online: 2022-09-13

Published Print: 2022-09

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Poluektova, E. U.

Mavletova, D. A.

Odorskaya, M. V.

Marsova, M. V.

Klimina, K. M.

Koshenko, T. A.

Yunes, R. A.

Danilenko, V. N.
License Information

Text and Data Mining valid from 2022-09-01

Version of Record valid from 2022-09-01
More Information

Article History

Received: 22 March 2022

Revised: 7 April 2022

Accepted: 12 April 2022

First Online: 13 September 2022

COMPLIANCE WITH ETHICAL STANDARDS

: The authors declare that they have no conflicts of interest. This article does not contain any studies involving animals or human participants performed by any of the authors.

Document is current

Any future updates will be listed below